Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care
06. septembra 2024
Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care06. septembra 2024 Eversheds Sutherland has advised Edwards Lifesciences on the US$4.2bn sale of its Critical Care product group to Becton, Dickinson and Company (BD). Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease. The Critical Care product group is an industry leader in advanced patient monitoring with advanced AI algorithms serving millions of patients globally. Kľúčové kontakty
Lee Harris Partner Londýn, Spojené kráľovstvo Antony Walsh Partner Londýn, Spojené kráľovstvo Barri Mendelsohn Partner Londýn, Spojené kráľovstvo Rachel Cooper Partner Nottingham, Spojené kráľovstvo Edward M. Tompkin-Haag Partner Londýn, Spojené kráľovstvo Kelly Holmes Partner Birmingham, Spojené kráľovstvo Philip Crosbie Partner Leeds, Spojené kráľovstvo Christopher Murray Partner Edinburgh, Spojené kráľovstvo Latest Insights
Latest News
Latest Podujatia
novinky pre klientov 02. júna 2026 Next stop, public ownership: Eversheds Sutherland advises DfT on GTR transi... zásadná správa 01. júna 2026 Eversheds Sutherland strengthens restructuring offering with senior partner... zásadná správa 01. júna 2026 Eversheds Sutherland strengthens Commercial Advisory practice with technolo... novinky pre klientov 28. mája 2026 Eversheds Sutherland advises Schroders Greencoat on acquisition of Dutch bi... virtual Spanish employment law training 02. júna 2026 2pm - 5pm (BST) Virtual virtual UK employment law training 09. júna 2026 1pm - 4pm (BST) Virtual virtual Nordic (Denmark, Finland, Norway and Sweden) employment law training 16. júna 2026 12.45pm - 4pm (BST) Virtual virtual Introduction to Swiss employment law 23. júna 2026 2pm - 5pm (GMT) Virtual |